Premier Alternatives

Galaxy Diagnostics

Research Triangle Park, NC · Founded 2009 · Privately Held (backing)

Developer of diagnostic tests intended for early-stage disease detection. Galaxy Diagnostics is based in Research Triangle Park, NC and was founded in 2009. Its last reported valuation was $25 million in Nov 2025. It has raised $6.8 million across 4 recorded rounds; the latest was a $3 million seed round in May 2026.

Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$6.8M
Last round
Seed Round
May 2026

Galaxy Diagnostics key facts

as of Oct 2026
  • Developer of diagnostic tests intended for early-stage disease detection.
  • Galaxy Diagnostics is valued at approximately $25.0M as of Oct 2026 (last reported valuation).
  • It has raised $6.8M across 4 recorded rounds; the latest was Seed Round ($3.0M) in May 2026.
  • Notable investors include Triangle Tweener Fund, Ariel Savannah Angel Partners, BRIDGE Angel Investors, Boston Harbor Angels, First Flight Venture Center — 8 tracked in total.
  • 1 investment vehicle was formed to buy Galaxy Diagnostics shares in the last 12 months, reporting $203K sold to 18 investors, per SEC Form D filings.
  • Galaxy Diagnostics has filed 5 Form Ds with the SEC since 2009, most recently Apr 2025 ($4.1M sold to 55 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$25.0M

Galaxy Diagnostics's last reported valuation, Nov 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Galaxy Diagnostics with a free account
  • ·Watch Galaxy Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Galaxy Diagnostics funding rounds

4 rounds
May 2026Seed Round$3.0MSEC filing▮
Apr 2025Seed Round$4.1MSEC filing▮
Aug 2023Seed Round$2.0MSEC filing▮
Jul 2014Seed Round$551KSEC filing▮
Full funding history →

Vehicles formed to buy Galaxy Diagnostics shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Galaxy Diagnostics shares, reporting $203K sold to 18 investors. Most recent filing May 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Companies with the most vehicle activity →

Galaxy Diagnostics valuation

Galaxy Diagnostics's last reported valuation was $25 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Galaxy Diagnostics raised?

Galaxy Diagnostics has raised $6.8 million across 4 recorded rounds since 2014. The largest was a $550,814 seed round in Jul 2014; the most recent was a $3 million seed round in May 2026.

Galaxy Diagnostics has filed 5 Form Ds with the SEC since 2009, most recently in Apr 2025 ($4.1 million sold to 55 investors).

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Galaxy Diagnostics shares, reporting $202,500 sold to 18 investors, per SEC Form D filings (most recent May 2026).

Galaxy Diagnostics investors

8 investors are on record for Galaxy Diagnostics, including Triangle Tweener Fund, Ariel Savannah Angel Partners, BRIDGE Angel Investors and Boston Harbor Angels. The seed round in May 2026 drew 45 investors.

About Galaxy Diagnostics

Developer of diagnostic tests intended for early-stage disease detection. The company develops diagnostic tests for various vector-borne diseases such as Bartonellosis and Lyme Disease among others and offers detection for low-abundance flea and tick-borne infections, enabling healthcare providers to have access to advanced tests for disease diagnosis and confirmation in patients.

Sector
Healthcare
HQ
Research Triangle Park, NC, United States
Founded
2009
Employees
19
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.